A Nomogram for Predicting Mortality in Patients with Pneumonia-Associated Acute Respiratory Distress Syndrome (ARDS)
Dong Huang,Dingxiu He,Linjing Gong,Wei Jiang,Rong Yao,Zongan Liang
DOI: https://doi.org/10.2147/jir.s454992
IF: 4.5
2024-03-09
Journal of Inflammation Research
Abstract:Dong Huang, 1, &ast Dingxiu He, 2, &ast Linjing Gong, 1, &ast Wei Jiang, 2, &ast Rong Yao, 3 Zongan Liang 1 1 Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 2 Department of Emergency Medicine, The People's Hospital of Deyang, Deyang, Sichuan, People's Republic of China; 3 Department of Emergency Medicine, Emergency Medical Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zongan Liang, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, People's Republic of China, Email Background: There is no predictive tool developed for pneumonia-associated acute respiratory distress syndrome (ARDS) specifically so far, and the clinical risk classification of these patients is not well defined. Our study aims to construct an early prediction model for hospital mortality in patients with pneumonia-associated ARDS. Methods: In this single-center retrospective study, consecutive patients with pneumonia-associated ARDS admitted into intensive care units (ICUs) in West China Hospital of Sichuan University in China between January 2012 and December 2018 were enrolled. The least absolute shrinkage and selection operator (LASSO) regression and then multivariate logistic regression analysis were used to identify independent predictors which were used to develop a nomogram. We evaluated the performance of differentiation, calibration, and clinical utility of the nomogram. Results: The included patients were divided into the training cohort (442 patients) and the testing cohort (190 patients) with comparable baseline characteristics. The independent predictors for hospital mortality included age (OR: 1.04; 95% CI: 1.02, 1.05), chronic cardiovascular diseases (OR: 2.62; 95% CI: 1.54, 4.45), chronic respiratory diseases (OR: 1.87; 95% CI: 1.02, 3.43), lymphocytes (OR: 0.56; 95% CI: 0.39, 0.81), albumin (OR: 0.94; 95% CI: 0.90, 1.00), creatinine (OR: 1.00; 95% CI: 1.00, 1.01), D-dimer (OR: 1.06; 95% CI: 1.03, 1.09) and procalcitonin (OR: 1.14; 95% CI: 1.07, 1.22). A web-based dynamic nomogram ( https://h1234.shinyapps.io/dynnomapp/ ) was constructed based on these factors. The concordance index (C index) of the nomogram was 0.798 (95% CI: 0.756, 0.840) in the training cohort and 0.808 (95% CI: 0.747, 0.870) in testing cohort. The precision–recall (PR) curves, calibration curves, decision curve analyses (DCA) and clinical impact curves showed that the nomogram has good predictive value and clinical utility. Conclusion: We developed and evaluated a convenient nomogram consisting of 8 clinical characteristics for predicting mortality in patients with pneumonia-associated ARDS. Keywords: pneumonia, acute respiratory distress syndrome, mortality, risk factors, nomogram Acute respiratory distress syndrome (ARDS) is a common life-threatening clinical syndrome in critically ill patients. It is characterized by bilateral chest radiographical infiltrates with severe acute hypoxemic respiratory failure due to diffuse lung inflammation and edema which is not fully explained by cardiac failure or fluid overload. 1 It is estimated that ARDS is present in about 10% of all patients in intensive care units (ICU) worldwide. 2 Progress has been made in developing an evidence-based treatment and supportive care for ARDS patients, such as lung-protective mechanical ventilation and limited fluid resuscitation, during the last decades. 3 However, no specific pharmacotherapies have been proved to be effective and thus, the mortality of ARDS remains high at approximately 40%. 2 Considering the high morbidity and mortality, it is of great significance to identify which category of ARDS patients will have a poor prognosis in advance. The early risk stratification provides an important basis for personalized intervention and treatment, which might help reduce the mortality of ARDS. Several prediction tools are available for predicting prognosis, such as the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA). 4 However, these widely used scoring systems in ICU are not specific enough for the evaluation of mortality in ARDS patients. The 2012 Berlin definition proposed three categories of ARDS patients based on degree of hypoxemia that correlated with mortality: mild (PaO 2 /FiO 2 ≤ 300 mmHg), moder -Abstract Truncated-
immunology